MedTrace Logo

Multi-omics Study and Drug Intervention Study of Spondyloarthritis

NCT05494203 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2022-08-12

No results posted yet for this study

Summary

Spondyloarthritis (SpA) is a type of chronic inflammatory rheumatic disease that mainly affects the spine and peripheral joints, or joints, ligaments and tendons. This disease subtype has the same clinical and immunological features. Further explore the pathogenesis of spondyloarthritis, explore the guiding significance of different imaging examinations for spondyloarthritis, and study the efficacy and mechanism of different drugs for spondyloarthritis.

Conditions

  • Spondylarthritis

Interventions

DIAGNOSTIC_TEST

questionnaire survey

All patients received lifestyle questionnaire, medical history, physical signs, auxiliary examination and laboratory examination results before treatment.

Sponsors & Collaborators

  • First Affiliated Hospital of Wenzhou Medical University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2022-12-31
Completion
2023-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05494203 on ClinicalTrials.gov